TP53 and hepatocellular carcinoma: Furthermore, TERTp and TP53 co-mutation are significantly enriched in patients with positive microvascular invasion, closely correlating with poor prognosis by promoting HCC cell proliferation and inhibiting immune cell infiltration in the surrounding tumor microenvironment [18].